在使用美托洛尔和甲基多巴进行慢性抗高血压治疗期间间歇性跛行患者的行走能力
Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa.
作者信息
Lepäntalo M, von Knorring J
出版信息
Clin Physiol. 1984 Aug;4(4):275-82. doi: 10.1111/j.1475-097x.1984.tb00803.x.
Abstract
In a placebo-controlled double-blind crossover trial, the effect of a 3-week course of treatment with metoprolol (100-200 mg daily) and methyldopa (500-1000 mg daily) on walking capacity on a treadmill with increasing work load was studied in 14 hypertensive patients with intermittent claudication. The walking capacity was not affected by the antihypertensive treatment.
摘要
在一项安慰剂对照的双盲交叉试验中，对14例患有间歇性跛行的高血压患者研究了为期3周的美托洛尔（每日100 - 200毫克）和甲基多巴（每日500 - 1000毫克）治疗疗程对在工作负荷增加的跑步机上行走能力的影响。行走能力不受降压治疗的影响。
Zotero 插件